Total Payments
$2,652
2024 Payments
$318.40
Companies
21
Transactions
137
Medicare Patients
240
Medicare Billing
$10,644
Payment Breakdown by Category
Food & Beverage$2,427 (91.5%)
Education$205.79 (7.8%)
Consulting$19.85 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,427 | 128 | 91.5% |
| Education | $205.79 | 8 | 7.8% |
| Consulting Fee | $19.85 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $657.84 | 32 | $0 (2023) |
| Lupin Inc. | $493.14 | 31 | $0 (2021) |
| PFIZER INC. | $244.08 | 16 | $0 (2024) |
| Sumitomo Pharma America, Inc. | $205.30 | 10 | $0 (2024) |
| Evofem Biosciences, Inc. | $158.46 | 8 | $0 (2024) |
| AMAG Pharmaceuticals, Inc. | $146.01 | 8 | $0 (2021) |
| Duchesnay USA Incorporated | $125.00 | 1 | $0 (2017) |
| Cumberland Pharmaceuticals, Inc. | $114.55 | 4 | $0 (2023) |
| Myovant Sciences Inc. | $107.40 | 5 | $0 (2022) |
| CSL Behring | $98.67 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $318.40 | 17 | Evofem Biosciences, Inc. ($88.56) |
| 2023 | $530.43 | 27 | AbbVie Inc. ($206.30) |
| 2022 | $406.94 | 20 | ABBVIE INC. ($132.66) |
| 2021 | $287.59 | 19 | AbbVie Inc. ($151.88) |
| 2020 | $279.47 | 21 | Lupin Inc. ($162.89) |
| 2019 | $445.96 | 20 | Lupin Inc. ($262.55) |
| 2018 | $237.62 | 10 | CSL Behring ($98.67) |
| 2017 | $145.83 | 3 | Duchesnay USA Incorporated ($125.00) |
All Payment Transactions
137 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Biological | ||||||
| 11/14/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $22.96 | General |
| 10/31/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $16.66 | General |
| Category: WOMENS HEALTH | ||||||
| 10/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: UROLOGY | ||||||
| 09/30/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, DUAVEE | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: WOMENS HEALTH | ||||||
| 08/23/2024 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $27.08 | General |
| Category: HORMONE THERAPY | ||||||
| 08/15/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.83 | General |
| Category: CONTRACEPTIVE | ||||||
| 08/06/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $23.45 | General |
| 07/15/2024 | Organon Llc | JADA SYSTEM (Device) | Food and Beverage | In-kind items and services | $5.43 | General |
| Category: POSTPARTUM UTERINE HEMORRHAGING | ||||||
| 06/13/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $20.18 | General |
| Category: CONTRACEPTIVE | ||||||
| 06/05/2024 | Organon Llc | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: ETONOGESTREL | ||||||
| 05/22/2024 | PFIZER INC. | PREMARIN (Drug), DUAVEE, MYFEMBREE | Food and Beverage | In-kind items and services | $22.53 | General |
| Category: WOMENS HEALTH | ||||||
| 05/10/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $20.06 | General |
| 04/26/2024 | Exeltis, USA Inc. | SLYND (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: CONTRACEPTIVE | ||||||
| 03/06/2024 | PFIZER INC. | PREMARIN (Drug), ESTRING, MYFEMBREE | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: WOMENS HEALTH | ||||||
| 02/14/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: Oncology | ||||||
| 01/23/2024 | Evofem Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $22.09 | General |
| 11/14/2023 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $24.16 | General |
| Category: WOMENS HEALTH | ||||||
| 11/07/2023 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $22.70 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 10/25/2023 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: WOMENS HEALTH | ||||||
| 10/24/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Biological | ||||||
| 10/11/2023 | Sumitomo Pharma America, Inc. | MYFEMBREE (Drug) | Food and Beverage | In-kind items and services | $13.66 | General |
| Category: HORMONE THERAPY | ||||||
| 10/04/2023 | AbbVie Inc. | ORILISSA (Drug) | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: WOMENS HEALTH | ||||||
| 09/05/2023 | Evofem Biosciences, Inc. | Phexxi (Drug) | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Miscellaneous vaginal agent | ||||||
| 08/29/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: Biological | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 44 | 46 | $5,056 | $2,302 |
| 2022 | 4 | 70 | 74 | $8,001 | $3,102 |
| 2021 | 4 | 74 | 76 | $8,122 | $3,363 |
| 2020 | 3 | 52 | 54 | $5,776 | $1,877 |
Total Patients
240
Total Services
250
Medicare Billing
$10,644
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 17 | 18 | $2,772 | $965.16 | 34.8% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2023 | 12 | 13 | $1,189 | $776.73 | 65.3% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2023 | 15 | 15 | $1,095 | $560.55 | 51.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 21 | 23 | $3,542 | $1,157 | 32.7% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2022 | 19 | 19 | $1,387 | $719.34 | 51.9% |
| 76830 | Ultrasound scan of uterus, ovaries, tubes, cervix and pelvic area through vagina | Office | 2022 | 15 | 15 | $1,372 | $711.24 | 51.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 15 | 17 | $1,700 | $514.29 | 30.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 24 | $3,696 | $1,157 | 31.3% |
| 76830 | Ultrasound pelvis through vagina | Office | 2021 | 12 | 12 | $1,097 | $835.75 | 76.2% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2021 | 22 | 22 | $1,606 | $831.38 | 51.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 16 | 18 | $1,722 | $539.72 | 31.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 18 | 18 | $2,772 | $752.37 | 27.1% |
| G0101 | Cervical or vaginal cancer screening; pelvic and clinical breast examination | Office | 2020 | 17 | 17 | $1,241 | $666.76 | 53.7% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 17 | 19 | $1,763 | $457.42 | 25.9% |
About Dr. Robert Russell, M.D
Dr. Robert Russell, M.D is a Specialist healthcare provider based in Minden, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1386671543.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Russell, M.D has received a total of $2,652 in payments from pharmaceutical and medical device companies, with $318.40 received in 2024. These payments were reported across 137 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($2,427).
As a Medicare-enrolled provider, Russell has provided services to 240 Medicare beneficiaries, totaling 250 services with total Medicare billing of $10,644. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Location Minden, LA
- Active Since 06/26/2006
- Last Updated 06/16/2011
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1386671543
Products in Payments
- MYFEMBREE (Drug) $407.56
- SOLOSEC (Drug) $401.48
- ORILISSA (Drug) $291.78
- LO LOESTRIN FE (Drug) $142.00
- Osphena (Drug) $125.00
- Orilissa (Drug) $100.00
- Rhophylac (Biological) $98.67
- INTRAROSA (Drug) $98.22
- LILETTA (Drug) $92.22
- SOLOSEC-CEEK (Drug) $91.66
- PREMARIN (Drug) $72.18
- Phexxi (Drug) $69.90
- NEXPLANON (Drug) $63.02
- KRISTALOSE (Drug) $59.68
- SLYND (Drug) $57.91
- Veozah (Drug) $45.96
- CALDOLOR (Drug) $32.40
- ORIAHNN (Drug) $31.84
- PREVNAR 13 (Biological) $30.28
- Balcoltra (Drug) $27.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.